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NEGLECTED TROPICAL DISEASES IN BRAZIL
José Angelo L. LINDOSO(1,2,3) & Ana Angélica B.P. LINDOSO(1,4,5)
SUMMARY
Poverty is intrinsically related to the incidence of Neglected Tropical Diseases (NTDs). The main countries that have the lowest 
human development indices (HDI) and the highest burdens of NTDs are located in tropical and subtropical regions of the world. 
Among these countries is Brazil, which is ranked 70th in HDI. Nine out of the ten NTDs established by the World Health Organization 
(WHO) are present in Brazil. Leishmaniasis, tuberculosis, dengue fever and leprosy are present over almost the entire Brazilian 
territory. More than 90% of malaria cases occur in the Northern region of the country, and lymphatic filariasis and onchocerciasis 
occur in outbreaks in a particular region. The North and Northeast regions of Brazil have the lowest HDIs and the highest rates of 
NTDs. These diseases are considered neglected because there is not important investment in projects for the development of new 
drugs and vaccines and existing programs to control these diseases are not sufficient. Another problem related to NTDs is co-infection 
with HIV, which favors the occurrence of severe clinical manifestations and therapeutic failure. In this article, we describe the status 
of the main NTDs currently occurring in Brazil and relate them to the HDI and poverty.
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INTRODUCTION
Neglected tropical diseases (NTDs) have a higher prevalence in regions 
between latitudes 35°N and 35°S, with altitudes below 2,200 meters and 
temperatures ranging from 15 °C to 40 °C. The populations living in these 
regions earn about US$ 1.00 a day and are considered the poorest people in 
the world. About 1.2 billion people worldwide who live in absolute poverty, 
mainly in three developing regions (sub-Saharan Africa, Asia, and Latin 
America), are vulnerable to NTDs20,21. In these regions, poverty is closely 
associated with the prevalence of NTDs and with increased vulnerability to 
such diseases. Infection by the causative agents of NTDs causes disability 
and disfigurement, with profound economic, social, and political impact. 
The direct effects of NTDs can be observed in health, education, agriculture, 
and the economy. NTDs may be caused by parasitic (helminthic and 
protozoan), bacterial, fungal, ectoparasitic, or viral agents. A group of 13 
diseases is responsible for about 57 million disability-adjusted life years 
lost per year18,20. More than 90% of the burden results from seven major 
diseases that are highly prevalent and difficult to control20. The classification 
of these diseases into three categories was based on emergence, control, 
and drug availability (World Health Organization, WHO). Category one 
includes the major NTDs (dengue fever, human African trypanosomiasis, 
and leishmaniasis), which are not under control and are emerging. Category 
two includes diseases (malaria, schistosomiasis, and tuberculosis) for 
which a control strategy is available, although the disease burden remains. 
Category three includes diseases (leprosy, Chagas’ disease, lymphatic 
filariasis, and onchocerciasis) for which the control strategy proved to 
be effective; the burden of these diseases is falling, and there is a plan 
for their elimination (Table 1). However, other diseases that are caused 
by helminthic and bacterial agents cause disability and handicap and are 
considered the highest-burden NTDs. NTDs have a global prevalence of 
about 2.60 billion20. Hookworm infection is the most prevalent disease, 
and the number of deaths caused by leishmaniasis, schistosomiasis, and 
human African trypanosomiasis is very high. 
This review focuses on the main NTDs occurring in Brazil and 
describes their status and problems related to their control, drug 
development, and association with poverty. 
BURDEN OF NEGLECTED TROPICAL DISEASES IN BRAZIL
According to the WHO, several of the world’s major NTDs occur 
in Brazil. However, the burden of these diseases differs by region. The 
number of people affected by NTDs is more elevated in areas with 
greater poverty. There is a direct relationship between the prevalence 
of these diseases and the human development index (HDI). There 
is a high prevalence of NTDs in Brazil and most of them occur 
in poor regions, mainly in the north and northwest of the country 
(Fig. 2). Malaria, Chagas’ disease, leishmaniasis, schistosomiasis, 
dengue fever, leprosy, onchocerciasis, and lymphatic filariasis are 
the NTDs with the highest prevalence rates14,16. Tuberculosis, which 
is not considered a tropical disease, is also highly prevalent in Brazil 
(Table 2). 
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LEISHMANIASIS
Leishmaniasis, which is caused by 20 species of the genus Leishmania 
sp., is pathogenic in humans and is transmitted by phlebotomine sandflies. 
The disease is prevalent on four continents and is considered to be 
endemic in 88 countries, of which 72 are developing countries. In terms 
of distribution, 90% of all cases of visceral leishmaniasis (VL) occur in 
Bangladesh, Brazil, India, Nepal, and the Sudan; 90% of all cases of the 
mucocutaneous form occur in Bolivia, Brazil, and Peru; and 90% of all 
cases of the cutaneous form occur in Afghanistan, Brazil, Iran, Peru, Saudi 
Arabia, and Syria49. Leishmaniasis is present in all regions of Brazil. About 
28,000 and 3,000 cases of tegumentary and visceral leishmaniasis are 
reported per year, respectively6. In Brazil, tegumentary leishmaniasis (TL) 
is caused by different species of Leishmania (L.), and VL is caused only 
by L. chagasi. Both cutaneous and mucosal TL cause disfigurement and 
visceral leishmaniasis is fatal if left untreated. TL and VL are most prevalent 
in the north and northeast regions, respectively6. The epidemiological 
pattern of VL has changed. In the eighties, 90% of cases occurred in the 
northeast region of Brazil; in the following decade, the disease was found 
to be disseminated in geographic areas with a higher level of development. 
VL and TL are currently present over the entire territory and the lethality 
rate of VL is about 5%6. Although the disease has been known for a long 
time, the therapeutic arsenal for the treatment of patients with leishmaniasis 
is poor. In Brazil, only three drugs are available, and they present several 
inconveniences for patients. Firstly, the drugs can be administered only by 
the parenteral route and their side effects include renal damage, pancreatitis, 
and cardiac damage. Secondly, an increase in drug resistance has been 
observed. Although the Brazilian program for the control of leishmaniasis 
is adequate, the disease is still spreading. This spread has been related to 
environmental changes such as deforestation, urbanization, and migration 
of non-immune people to endemic areas9.
MALARIA
Malaria is caused by the Plasmodium (P.) species and is transmitted 
by bites of the female Anopheles mosquito. In Brazil, the disease is caused 
by P. vivax, P. malariae, and P. falciparum, which is responsible for the 
most serious form of the disease. 
Data from the Health Ministry about malaria in Brazil show a 
clear decrease in the number of cases in the last two years as a result 
of integrated action by the federal, state, and municipal governments. 
In 2007, 457,659 cases of malaria were notified, whereas in 2005 there 
had been 607,827. This represents a 150,168 (24.7%) reduction in the 
number of sick people between 2005 and 20076. This decrease is the 
result of continuous efforts carried out by the Health Department in 
cooperation with the state and municipal governments. According to 
the Health Ministry, the success in “the control of Malaria results from 
continuous efforts carried out through the integration of surveillance and 
improvement in population access to health services”6. 
Table 1
Distribution of Neglected Tropical Diseases according to categories. (Based on panel from the TDR/World Health Organization)
Category 1. 
Emerging and 
uncontrolled disease
Category 2.
Control strategy available 
Disease burden persists
Category 3.
Control strategy effective
Disease burden falling
Elimination planned
Leishmaniasis
African Trypanosomiasis
Dengue fever
Malaria
Schistosomiasis
Tuberculosis
Chagas’ Disease
Leprosy
Lymphatic filariasis
Onchocerciasis
Table 2.
Estimated burden of the main Neglected Tropical Diseases reported in Brazil over ten years (from 1998 through 2007)
Neglected Tropical Diseases Total number of reported cases Number of deaths Case fatality rate
Visceral Leishmaniasis 33,787 1,598 4.73%
Tegumentary Leishmaniasis (a) 268,866 616*** 0.22%
Malaria 4,791,853 960 0.02%
Dengue fever 3,317,662 463 0.013%
Tuberculosis 631,887 22,937 3.3%
Chagas’ Disease* 444 14 3%
Schistosomiasis 1,031,838 4,539 0.43%
Leprosy**(a) 405,860 11,794 2.9%
Source: Health Surveillance Service of the Ministry of Health of Brazil and DATASUS. Death by (a) were not considered basic cause of dead. * Data 
available only for Acute Chagas’ Disease from 2005 through 2008; ** Data available from 2004 to 2006; *** Data available from 2001 to 2007.
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Between 2006 and 2007, the state of Acre showed the most significant 
reduction in malaria cases, followed by Maranhão (-45.4% and -30.5%, 
respectively). The states of Tocantins and Rondônia also showed a 
decrease (24% and 19.5%, respectively). Only the states of Amazonas and 
Mato Grosso showed an increase in the number of cases, with increases 
of 6.0% and 1.5%, respectively. Brazil also showed an overall reduction 
in the number of deaths and hospital admissions6. In Legal Amazonia, a 
zone that covers 99.9% of malaria notifications in the country, there was 
a 54.4% reduction in the number of deaths8. Increases in the number of 
laboratories for the diagnosis of malaria (1,182 and 3,217 laboratory units 
in 1999 and 2007, respectively) and the introduction of new treatments for 
patients with malaria transmitted by P. falciparum were the main factors 
that contributed to this reduction4. These points decisively contributed 
to improving care for patients with malaria. 
Better intersectorial integration and articulation are necessary to 
improve these results. Concerted action is expected from the Ministries of 
Agrarian Reform, Mines and Energy, Transport, Defense, Education, and 
Tourism to diminish eventual divergences, with a focus on the effective 
control of malaria3,4. 
Since a vaccine against the disease is not yet available, adequate 
access to opportune diagnosis and intervention is necessary to avoid 
unnecessary deaths3,4. 
CHAGAS’ DISEASE
Chagas’ disease is transmitted mainly by Triatoma insects. At the 
end of the seventies, a high incidence of Chagas’ disease was observed 
in Brazil, with about 100,000 new cases per year. The chronic form of 
the disease can cause lesions such as cardiac failure, arrhythmia, and 
mega-intestine, causing poor quality of life and precocious death43. 
An efficient program that includes entomologic monitoring to identify 
the presence of the vector, anti-vector initiatives with specific insecticidal 
action, and the improvement of living conditions in endemic areas will 
keep the disease under control. A 0.13% prevalence of Chagas’ disease 
was observed in a multicenter study that included all endemic states in 
Brazil from 1989 to 1999; the study was carried out with the participation 
of children (aged 7-14 years) attending primary school43. With these data, 
ten Brazilian states (São Paulo, Rio de Janeiro, Paraíba, Mato Grosso, 
Mato Grosso do Sul, Goiás, Minas Gerais, Pernambuco, Tocantins, 
and Piauí) were certified (International Commission of Specialists of 
the Pan-American Health Organization, PAHO) for the interruption of 
vectorial transmission of Chagas’ disease by T. infestans. Similar studies 
are being conducted in other states, and the Health Authorities are 
expected to obtain the same certification. T. infestans is no longer found 
in seven states of Brazil. In the Amazon region, changes in landscape, 
the migration of populations from Chagas-endemic areas, the diversity of 
wild T. cruzi reservoir hosts, and the variety of vector species resulted in 
intense sylvatic transmission. Since such condition favors the emergence 
and expansion of Chagas’ disease, the development of specific actions 
is necessary to control the disease in the Amazon area6. In Brazil, 
transfusional transmission is controlled and other vectors are under 
surveillance. In the same vein, procedures such as the improvement of 
household and living conditions were undertaken, aiming at a proximate 
interruption of vectorial transmission. Currently, the main problem is 
related to chronic patients who present cardiac failure or mega-colon; 
the occurrence of acute Chagas’ disease in foci and transmission by oral 
ingestion are additional problems. Some reports of outbreaks in different 
areas of Brazil show a relationship between Chagas’ disease and the 
ingestion of açaí35, a typical food of Amazonas, and sugarcane juice45.
DENGUE FEVER
Dengue illness is caused by any of four different serotypes. It is 
currently considered the most important mosquito-borne viral disease 
in humans who live in the tropical and subtropical areas of the world. 
Dengue is one of the main public health problems in the world. The 
WHO indicates that 50 to 100 million people are infected annually in 
more than 100 countries, on all continents except Europe. About 550,000 
sick people need hospitalization and 20,000 die as a consequence of the 
disease. Dengue is a disease with a wide clinical spectrum. The prognosis 
of dengue hemorrhagic fever depends on early diagnosis and treatment, 
which can reduce the disease’s lethality24. In Brazil, social conditions 
such as poverty, poor sanitation and education, as well as environmental 
determinants such as temperature, latitude, longitude, and disorganized 
urbanization, favored the expansion of Aedes aegypti and facilitated its 
dispersion since it was re-introduced in 19766. This vector has a high 
capacity of adaptation to urban conditions and could not to be controlled 
with traditional methods. In Brazil, dengue fever generally occurs from 
January to May. Since 1996, it has occurred every year throughout the 
country. Serotype 3 is the strain with the highest circulation; serotypes 
1 and 2 also occur, although with a lower frequency. Programs based on 
chemical management, which typically involve little participation from 
the community, were unable to control vector dissemination. In 1990, 
the introduction and rapid dissemination of serotype 3 paved the way 
for large-scale epidemics and increases in the number of cases of the 
hemorrhagic form. Brazilian health authorities extended the control of 
disease progression with the National Plan for the Control of Dengue 
(PNCD). The PNCD fortified surveillance as a health priority, with 
initiatives such as educational campaigns, population mobilization to 
keep potential niches in the environment free of vectors, improvement in 
both health professionals’ qualifications and vector combat, and continued 
evaluation of control initiatives in states and cities. The dissemination of 
arboviruses is related to poverty, low wages, and health care inequity26. 
Yellow fever, another arbovirus disease, is difficult to control and is 
not related only to poverty. The main problem is that arboviruses are 
present in tropical countries, particularly in countries where great social 
differences contribute to making people more vulnerable to this kind of 
diseases26. 
TUBERCULOSIS
Tuberculosis (TB) is an important public health problem in 22 
developing countries. Eighty percent of the worldwide cases occurred 
in these countries. According to recent estimates, about one-third of 
the worldwide population is infected with Mycobacterium tuberculosis 
and is thus at risk of developing the disease10. Eight million new cases 
and almost three million deaths are registered every year. In developed 
countries, aged people, ethnic minorities, and immigrants are the most 
affected. In developing countries, the economically active population 
(aged 15-54 years) is also affected by TB4. Males are twice as susceptible 
to this disease as women. In these countries, determinant factors such as 
poverty, alcohol abuse, and malnutrition influence vulnerability to this 
infectious disease3. In Brazil, more than 50 million people are infected 
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with the TB bacillus6. About 100,000 new cases are notified every year 
and there are about five thousand to six thousand yearly deaths due to 
this disease6. Acquired Immunodeficiency Syndrome (AIDS) was a 
determinant factor in the resurgence of TB50. In developed countries, the 
increase in the number of cases of multidrug-resistant TB (MDR-TB) is 
another concerning problem. In Brazil, intermediate-level incidence of 
MDR-TB has been observed47. The association of tuberculosis and AIDS 
has become a serious public health problem, raising the morbidity and 
mortality indices of TB10. Although TB is a serious disease, it is curable 
in most new cases. In parallel to prove treatment for TB patients, health 
authorities also want to eliminate the major sources of infection6. In São 
Paulo city (2002), 416 deaths occurred from non-AIDS-associated TB27. 
Male adults over 50 years of age, migrants, and people living in districts 
with a low-ranked HDI are more likely to die from TB. Low education 
level and co-morbidity are relevant characteristics. Low involvement of 
primary care units in TB diagnosis and frequent underreporting of cases 
were also analyzed in that study27. It is important to emphasize that both 
AIDS and TB treatments are free of charge and available in hospitals of 
the Public Health System, thus contributing to improvement of the control 
of these diseases. In Brazil, the introduction of highly active antiretroviral 
therapy had an important impact on the decrease in the number of cases 
of HIV/TB co-infection. 
LEPROSY
Leprosy is another disease intrinsically related to poverty. The global 
prevalence of this disease is estimated to be 0.4 million people, mainly 
in India, sub-Saharan Africa, Latin America, and the Caribbean11. India 
and Brazil belong to the 20 countries in the world with the greatest 
economic power but they are among the countries most affected by 
leprosy. This contrast highlights the social and economic inequalities 
present in developing countries. In light of this, there will be soon a 
significant number of new cases of people with leprosy, with many of 
them presenting disabilities, if no effective action is taken11. Although 
there is a good program for the control of leprosy in Brazil, the number 
of cases is still high. In 2006, the prevalence rate for leprosy in Brazil was 
2.37 cases per 10,000 inhabitants6. Although a decline in prevalence has 
been observed since 1990, the rate remains high. Regarding the detection 
rate, Brazil is hyperendemic in the north and center-west regions; the level 
of endemicity is very high in the northwest and high in the southeast, 
center, and south regions. According to the National Public Health 
Surveillance Program in Brazil, the states of Maranhão, Pará, and Mato 
Grosso present the highest number of patients with leprosy6. The state 
of Maranhão has the lowest DHI in Brazil, thus confirming the intrinsic 
relationship between leprosy and poverty. Although treatment for patients 
with leprosy is effective, with a cure rate of 90%, its availability and 
effectiveness depends on the public health systems, especially in terms 
of quality and accessibility to medicines.
SCHISTOSOMIASIS
Schistosomiasis is intrinsically related to poverty and the absence 
of adequate sanitary conditions12. The impact of schistosomiasis can 
be observed in economic production, in cognitive impairment among 
pre-school children, and, consequently, in the country’ development2. 
In Brazil, schistosomiasis is caused by Schistosoma mansoni, which is 
present in almost all territory. The disease is present in 19 states; it is 
endemic in eight states, with six and two of these states in the northwest 
and southwest regions of Brazil, respectively6. Foci of the disease occur in 
other states (Pará, Maranhão, Piauí, Ceará, Rio de Janeiro, Santa Catarina, 
São Paulo, Rio Grande do Sul, and Goiás) and in Brasília. However, the 
migration of people from a schistosomiasis-endemic area to areas free 
of the disease could contribute to disseminating the disease6. The disease 
can exhibit a wide spectrum of symptoms.
The national schistosomiasis control program, which was implemented 
in 1975, was based on: 1) improvement of sanitary conditions, including 
water supply, and the construction of bathrooms and septic tanks; 2) sanitary 
education efforts in order to reduce high-risk behavior; 3) active and 
passive case detection and large-scale chemotherapy; and 4) snail control 
according to epidemiological and ecological characteristics (WHO, 1983, 
2000). After the control program was implemented in Brazil, a reduction 
in the prevalence of Schistosoma mansoni was observed in some areas2; 
in addition, the number of hospitalized individuals fell by 65% between 
1988 and 1999, and specific mortality due to schistosomiasis fell by 54% 
between 1979 and 19976. Similarly, the mean age at death associated with 
schistosomiasis rose by 32.2% between 1976 and 20032,6. Despite the 
decrease of schistosomiasis cases in Brazil, the disease may be considered 
an NTD. Currently, there are only two effective drugs available in Brazil 
for the treatment of patients with schistosomiasis25. Additionally, it is too 
difficult for the patients to access these drugs in some parts of the country. 
In some regions, it is also difficult for them to access a health service to 
diagnose schistosomiasis. 
ONCHOCERCIASIS
Onchocerciasis is caused by the filarial nematode Onchocerca 
volvulus and is transmitted from person to person by blood-sucking 
black flies30,44. The main clinical manifestations are onchocercal skin 
disease and ocular lesions that lead to visual impairment and blindness. 
Cutaneous lesions are classified into acute and chronic papular dermatitis, 
lichenified dermatitis, atrophy, and depigmentation46. In 1995, the WHO 
estimated that a total of 17.7 million people were infected with O. 
volvulus; 270,000 were blind and another 500,000 had visual impairment. 
Recent reports indicate that these data were underestimated: 37 million 
people are now thought to be infected, with 90 million more at risk, 
in sub-Saharan Africa, and there are an estimated 400,000 infections 
in Latin America. In Africa, the disease is considered to have a high 
prevalence and morbidity has increased29. In the Americas, foci of the 
disease were found in six countries (Mexico, Guatemala, Colombia, 
Ecuador, Venezuela, and Brazil). There were an estimated thirteen foci 
of the disease on the American continent according to the WHO48. In 
Brazil, the disease occurs in the states of Roraima and Amazonas. In 
Brazilian Amazonia, the focus covers a large part of the Yanomami 
Indian territory in northwestern Roraima and central and northern 
Amazonas. There are about 17,000 Yanomami Indians and 10,000 of 
them are at risk of developing onchocerciasis6. However, statistical data 
on the number of Indians infected with O. volvulus are not available. 
Onchocerciasis, as well as other NTDs, has not received the due attention 
from the government regarding treatment and control. In relation to 
specific medicines for the treatment of patients with onchocerciasis, 
some efficacious drugs are currently available46. 
LYMPHATIC FILARIASIS
Lymphatic filariasis is caused mainly by Wuchereria brancrofti 
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and transmitted by Culex quinquefasciatus. It causes a chronic 
disease and is considered one of the main causes of disability due to 
infectious disease in the world. At the same time, filariasis causes social 
stigmatization and decrease in both job opportunities and quality of 
life32. The disease is prevalent in certain parts of the world, particularly 
in Africa, Caribbean, and Latin America16,37. In Brazil, the prevalence 
rate is not available from the Health Surveillance Service, but disease 
transmission in the Metropolitan Region of Recife, Pernambuco State, 
is a cause for concern33. Regarding treatment of patients with filariasis, 
some effective drugs are available but access to both diagnosis and 
drugs is again the main problem20. The incidence of the filarial carrier 
can be reduced by massive treatment. This can be observed in some 
regions of Brazil where such treatment was implemented6. Although 
filariasis is a public health problem in Brazil, it was considered by the 
WHO one of the seven diseases for which it is likely to achieve global 
eradication by 2020. 
HOOKWORM INFECTION
Hookworm infection is a serious health problem, mainly with regard 
to disability5. This is the second most important parasitic infection in 
humans after malaria7. This infection is included in a group of major 
poverty-promoted chronic and disabling tropical infections considered 
as NTDs. Necator americanus and Ancylostoma duodenale, which are 
nematode parasites, are considered the main causes of human hookworm 
infection7. They are distributed in most parts of the world, mainly in 
developing regions of the tropics, occurring in rural areas of extreme 
poverty20. About 600 million individuals with hookworm infection 
are distributed mainly in agricultural areas inhabited by about 2.7 
billion people who live on less than $2 per day20,31. Environment and 
socioeconomic status are the two most important factors determining 
how hookworm infection is acquired31. In the Americas, its prevalence 
is estimated to be about 50 million cases. The mechanism by which 
poverty favors hookworm infection is based on inadequate sanitation, 
poor housing construction, and lack of access to essential medicines13. In 
Brazil, the factors described above are present in some places, mainly in 
the rural areas of the north and northeast regions. There is a high number 
of people with hookworm infection in these areas, which is in agreement 
with the assumption that poverty strictly favors hookworm infection. 
Although medicines are currently available for the treatment of patients 
with this disease, the major obstacle is drug distribution7.
CO-INFECTION WITH NTDs AND HIV
Another problem related to NTDs is co-infection with HIV22. The 
burden of NTDs in HIV-infected patients around the world has increased. 
Since 1980, visceral leishmaniasis (VL) has reemerged in Mediterranean 
countries, mainly among HIV-infected drug users1. Currently, an increase 
has been observed in the number of Leishmania-HIV co-infected patients, 
who have different clinical presentation or fail to respond to specific anti-
Leishmania treatment1. Recently, we reported a case series of patients 
with HIV infection and tegumentary leishmaniasis (TL) with unusual 
manifestation28, and TL was described as a manifestation of immune 
reconstitution inflammatory syndrome in HIV-infected patients38. Data 
from the Epidemiological Surveillance Center in São Paulo show that 
the rate of failure of treatment with liposomal amphotericin B in patients 
with VL infection is higher in HIV-co-infected patients than in those not 
infected with HIV. 
In patients co-infected with malaria and HIV, malaria contributes 
to worsening the immunosuppression caused by HIV infection. There 
is evidence that non-pregnant women infected with HIV are more 
vulnerable to malaria than those without HIV infection3,4. Chagas’ 
disease is also affected by HIV infection. It has been observed that, in 
patients with the chronic form of Chagas’ disease, the acute form of 
the disease reactivates due to the severe immunosuppression caused by 
HIV infection41,42. Also, leprosy can course with a more severe clinical 
manifestation in HIV-infected patients. Recently, we observed that HIV 
infection can modify the manifestation of paracoccidioidomycosis in 
severely immunosuppressed patients (personal communication). 
Co-infection with HIV and NTDs can course with more severe 
manifestations or lead to failure to respond to specific treatments. In 
fact, co-infection with HIV and NTDs is a new type of co-morbidity that 
requires additional knowledge and greater integration between HIV and 
NTD research than currently observed.
CONCLUDING REMARKS
NTDs occur in areas where poverty is endemic23. It is generally 
accepted that NTDs and low-level HDI are related31. This association 
can be confirmed by observing the prevalence of the main NTDs in the 
world. These diseases are prevalent in tropical and subtropical areas (Fig. 
1), in countries with a high index of poverty, and where most inhabitants 
live on less than two dollars a day. In Brazil, NTDs are most prevalent 
in the north and northeast regions, which present the lowest HDIs in the 
country (Fig. 2). According to the WHO, the main NTDs can be classified 
into three groups. Leishmaniasis, human African trypanosomiasis (HAT), 
and dengue fever are considered the most important NTDs. All other 
NTDs except for HAT occur in various regions of Brazil. TL, VL, and 
dengue fever occur all over the territory and malaria occurs mainly in 
northern Brazil. Other NTDs occur in outbreaks, like onchocerciasis, 
which is limited to the Yanomami Indian area (north region), and 
lymphatic filariasis, which occurs only in the Metropolitan region 
of Recife (Pernambuco State). The situation is different in the USA, 
where soil-transmitted helminth infections, which are most prevalent 
among immigrants, refugees, and Black women, are the main neglected 
infectious diseases; these infections are also typical of poverty15. In 
Brazil, the populations most affected by NTDs live in rural areas and in 
suburbs of large cities, where there is the highest prevalence of poverty31. 
Co-factors such as deforestation, sparse health service coverage, and lack 
of control of natural resources, may even worsen poverty20. Co-infection 
with HIV is a new problem related to NTDs22. In cases of co-infection, 
NTDs show different clinical manifestations or the patients fail to respond 
to specific treatments. In terms of drug availability and drugs developed 
exclusively for NTDs, the investments are clearly insufficient39. Although 
1,556 new drugs were developed in the world from 1975 to 2004, only 21 
of them are indicated for patients with NTDs40. Vaccines might be used 
either as lone control tools or combined with specific drugs in programs 
of vaccine-linked chemotherapy to prevent these diseases. However, an 
effective vaccine is not yet available17,36. Certain obstacles make it difficult 
to develop NTD vaccines. One of these obstacles is that many NTDs are 
zoonoses that occur in large mammalian reservoirs, and the development 
of veterinary vaccines would be necessary to interrupt transmission. 
The eradication or reduction of NTDs would have a direct effect on 
socioeconomic development and poverty17,19. Because such vaccines 
are specific to NTDs, they are sometimes referred to as ‘antipoverty’ 
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vaccines19. Although investment in NTDs has increased, stronger efforts 
by governmental and private organisms are required to decrease the 
morbidity and mortality caused by these diseases18,34. 
RESUMO
Doenças tropicais negligenciadas no Brasil
A pobreza está intrinsicamente relacionada com a ocorrência de 
doenças tropicais negligenciadas (DTNs). Os principais países com os 
menores índices de desenvolvimento humano (IDH) e a maior carga de 
DTNs estão nas regiões tropicais e subtropicais do globo terrestre. O 
Brasil é o 70o país no ranking do IDH e concentra nove das 10 principais 
doenças tropicais consideradas negligenciadas pela OMS. Leishmanioses, 
tuberculose, dengue e hanseníase ocorrem em quase todo o território do 
Brasil. Mais de 90% dos casos de malária ocorrem na região norte e há 
surtos de filariose linfática e oncocercose. As regiões norte e nordeste 
apresentam o menor IDH e concentram o maior número das DTNs. Essas 
doenças são consideradas negligenciadas devido à falta de investimento 
no desenvolvimento de novas drogas e vacinas e também pela pouca 
eficácia dos programas de controle. Um problema preocupante em relação 
às DTNs é a co-infecção com HIV, que favorece manifestações clínicas 
graves e falência terapêutica. Neste artigo, a situação das principais DTNs 
no Brasil é descrita e correlacionada com o IDH e a pobreza.
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